Search Results - Deborah L. Toppmeyer

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer by Mridula A. George, Sadaf Qureshi, Coral Omene, Deborah L. Toppmeyer, Shridar Ganesan

    Published in Frontiers in Oncology (2021-07-01)
    Get full text
    Article


  2. 2

    Adapting and implementing breast cancer follow-up in primary care: protocol for a mixed methods hybrid type 1 effectiveness-implementation cluster randomized study by Sarah J. Fadem, Benjamin F. Crabtree, Denalee M. O’Malley, Lisa Mikesell, Jeanne M. Ferrante, Deborah L. Toppmeyer, Pamela A. Ohman-Strickland, Jennifer R. Hemler, Jenna Howard, Alicja Bator, Ayana April-Sanders, Rachel Kurtzman, Shawna V. Hudson

    Published in BMC Primary Care (2023-11-01)
    Get full text
    Article


  3. 3

    Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. by Madhura S Mehta, Sonia C Dolfi, Roman Bronfenbrener, Erhan Bilal, Chunxia Chen, Dirk Moore, Yong Lin, Hussein Rahim, Seena Aisner, Romona D Kersellius, Jessica Teh, Suzie Chen, Deborah L Toppmeyer, Dan J Medina, Shridar Ganesan, Alexei Vazquez, Kim M Hirshfield

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


Search Tools: